Adolescents and young adults

In recent years, adolescent and young adult oncology has emerged as a distinct field due to lack of progress in survival and quality-of-life outcomes (Ferrari et al. 2010; Smith et al. 2013). The significant developmental change that occurs during this life stage complicates a diagnosis of cancer, often leading to unique physical, social and emotional…

Read More

Statement of acknowledgement

We acknowledge the Traditional Owners of Country throughout Australia and their continuing connection to the land, sea and community. We pay our respects to them and their cultures and to Elders past, present and emerging. This work is available from the Cancer Council website. First published in May 2015. This edition published in June 2021.…

Read More

Paediatrics

The rarity and complexity of childhood cancer provides a real challenge in delivering optimal care. Despite overall survival rates of more than 80 per cent (Cancer Australia 2015b), treatments for paediatric cancer are often prolonged and complicated and have a narrow therapeutic index. High-quality evidence-based care is required not only to deliver therapy and supportive…

Read More

Appendix D: Complementary therapies

Complementary therapies may be used together with conventional medical treatments to support and enhance quality of life and wellbeing. They do not aim to cure the patient’s cancer. Instead, they are used to help control symptoms such as pain and fatigue (Cancer Council Australia 2019). The lead clinician or health professional involved in the patient’s…

Read More

People experiencing socioeconomic disadvantage

In general, people from lower socioeconomic groups are at greater risk of poor health, have higher rates of illness, disability and death, and live shorter lives than those from higher socioeconomic groups (AIHW 2016). People experiencing socioeconomic disadvantage are less likely to participate in screening programs, more likely to be obese, less likely to exercise…

Read More

Appendix B: Psychological needs

Patients who have undergone stem cell transplants may have cognitive impairments for up to three years post procedure (Sharafeldin et al. 2018). Long-term follow-up and identification of strategies (e.g. maintaining written notes and repeating information) to enable patients to cope with alterations in cognitive function may be required. High-dose chemotherapy is both physically and emotionally…

Read More

Appendix A: Supportive care domains

Supportive care in cancer refers to the following five domains: the physical domain, which includes a wide range of physical symptoms that may be acute, relatively short lived or ongoing, requiring continuing interventions or rehabilitation the psychological domain, which includes a range of issues related to the patient’s mental health wellbeing and personal relationships the…

Read More

Sexually and gender diverse groups

People who identify as sexually or gender diverse may have unique needs following a cancer diagnosis. Sexually or gender diverse identities include (but are not limited to) people who identify as lesbian, gay, bisexual or transgender, collectively ‘LGBT’. There is no universally agreed upon initialism to describe this community, with other terms such as queer/questioning…

Read More

People with chronic mental health or psychiatric concerns

A diagnosis of cancer may present additional challenges to people who have pre-existing chronic mental health or psychiatric concerns, resulting in exacerbation of their mental health symptoms. This may include heightened anxiety, worsening depression or thoughts of self-harm. As poor adjustment and coping can affect treatment decisions, people who are known to have a mental…

Read More

Expert working group (previous edition)

Professor John Seymour (Chair), Director, Department of Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital Dr Phillip Campbell, Head of Haematology, Barwon Health Dr Duncan Carradice, Haematologist, Western Health Dr Geoff Chong, Medical Oncologist, Austin Health, Ballarat Regional Integrated Cancer Centre Ms Tracey Dryden, National Lymphoma Coordinator, Leukaemia Foundation Ms Jane Farrow, Senior…

Read More